AstraZeneca partners with AI company to find cure for cancer
The collaboration aims to create a zero-shot generative AI model that would work on creating new antibody therapeutics and enhancing existing ones.
The collaboration aims to create a zero-shot generative AI model that would work on creating new antibody therapeutics and enhancing existing ones.
Original source
Read on CointelegraphRelated market context
Are 24/7 CME Bitcoin futures a volatility cure — or a new leverage trap?
Wall Street got to trade Bitcoin around the clock just in time to watch the market fall apart. CME Group launched 24/7 trading for...
XRP aims for $0.90 as ETF demand battles selling pressure from whales
XRP is trading at $1.11, down roughly 17% from its June opening, having set a new 2026 low on June 5 and shed $8 billion in market...
Crypto’s World Cup play: Kraken, Chainlink, and Algorand stake claims while USMNT sits on the sidelines
The USMNT's lack of crypto partnerships highlights missed opportunities for fan engagement and revenue in a rapidly growing digita...
FIFA World Cup 2026 crypto partnerships get massive visibility boost as tournament enters group stage
The 2026 FIFA World Cup's crypto partnerships highlight the growing institutional adoption of digital assets, impacting investor s...
GameStop SEC Filing Highlights Coinbase Custody Liquidation Risk For Bitcoin Holdings
TL;DR GameStop’s Form 10-Q includes digital asset custody risk disclosures. The filing discusses circumstances in which a custodia...
Faker secures triple kill in crucial LCK match, but crypto implications are basically zero
Faker's gameplay brilliance highlights esports' cultural impact, but without strategic crypto integration, financial effects remai...